https://www.indianpharmapost.com/gland-pharma-reports-robust-q3-fy26-results-revenue-up-22-adj-pat-soars-37-189952026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/lonza-posts-chf-65-billion-in-2025-sales-marks-strong-profit-growth-190072026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/siegfried-expands-us-footprint-with-major-acquisition-of-noramco-extractas-bioscience-190062026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/biomed-x-launches-groundbreaking-ai-driven-diabetes-research-in-barbados-190052026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-pledges-15-billion-investment-in-china-through-2030-190042026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/moderna-teams-up-with-recordati-to-commercialize-rare-disease-therapy-190032026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/vetter-to-invest-480-million-in-major-german-manufacturing-expansion-eyes-2000-jobs-190022026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/vimta-labs-reports-10-yoy-growth-in-q3-fy26-pat-margins-hold-at-175-190012026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-posts-strong-q3fy26-results-revenue-up-18-pat-soars-47-190002026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/mabtech-sai-life-sciences-launch-strategic-collab-to-revolutionize-immunology-research-189992026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/shilpa-medicare-mabtree-biologics-win-fda-nod-for-rare-blood-cancer-therapy-189982026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/wanbury-unveils-api-facility-in-tanuku-targets-rs-100-crore-revenue-189972026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-gets-credit-boost-from-sp-outlook-stable-189962026-01-30T00:00:00+05:30always0.9https://www.indianpharmapost.com/fides-launches-imaging-cro-focused-on-early-phase-clinical-decision-making-190082026-01-30T00:00:00+05:30always0.9